Product
AB-836
1 clinical trial
1 indication
Indication
Chronic HepatitisClinical trial
A Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Dose Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AB-836, an HBV Capsid Inhibitor, in Healthy Subjects and Subjects With Chronic HBV InfectionStatus: Terminated, Estimated PCD: 2022-11-17